ES2547827T8 - Procedimiento para la purificación de la micafungina - Google Patents

Procedimiento para la purificación de la micafungina Download PDF

Info

Publication number
ES2547827T8
ES2547827T8 ES12713998.8T ES12713998T ES2547827T8 ES 2547827 T8 ES2547827 T8 ES 2547827T8 ES 12713998 T ES12713998 T ES 12713998T ES 2547827 T8 ES2547827 T8 ES 2547827T8
Authority
ES
Spain
Prior art keywords
micafungin
purification
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12713998.8T
Other languages
English (en)
Other versions
ES2547827T3 (es
Inventor
Lene Aassveen
Eli Karin Dale
Espen Fridtjof Hansen
Kjersti Meldahl Eide
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Xellia Pharmaceuticals ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals ApS filed Critical Xellia Pharmaceuticals ApS
Application granted granted Critical
Publication of ES2547827T3 publication Critical patent/ES2547827T3/es
Publication of ES2547827T8 publication Critical patent/ES2547827T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • B01D15/325Reversed phase
    • B01D15/327Reversed phase with hydrophobic interaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Photolithography (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
ES12713998.8T 2011-04-20 2012-04-13 Procedimiento para la purificación de la micafungina Active ES2547827T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161477190P 2011-04-20 2011-04-20
US201161477190P 2011-04-20
PCT/EP2012/056768 WO2012143293A1 (en) 2011-04-20 2012-04-13 Method for purification of micafungin

Publications (2)

Publication Number Publication Date
ES2547827T3 ES2547827T3 (es) 2015-10-08
ES2547827T8 true ES2547827T8 (es) 2015-10-21

Family

ID=45953151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12713998.8T Active ES2547827T3 (es) 2011-04-20 2012-04-13 Procedimiento para la purificación de la micafungina

Country Status (18)

Country Link
US (1) US9132163B2 (es)
EP (2) EP2699327B1 (es)
JP (1) JP5992507B2 (es)
KR (1) KR101944512B1 (es)
CN (1) CN103533995B (es)
AU (1) AU2012244435B2 (es)
BR (1) BR112013026420A2 (es)
CA (1) CA2832145C (es)
DK (1) DK2699327T3 (es)
ES (1) ES2547827T3 (es)
HR (1) HRP20151033T1 (es)
HU (1) HUE027806T2 (es)
IL (1) IL228913A (es)
PL (1) PL2699327T3 (es)
RS (1) RS54240B1 (es)
RU (1) RU2583262C2 (es)
SI (1) SI2699327T1 (es)
WO (1) WO2012143293A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012143293A1 (en) * 2011-04-20 2012-10-26 Xellia Pharmaceuticals Aps Method for purification of micafungin
CN102775476B (zh) * 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
CN105254721B (zh) * 2014-05-13 2021-05-18 江苏豪森药业集团有限公司 米卡芬净的纯化转盐方法
US10183973B2 (en) * 2014-05-29 2019-01-22 Shanghai Techwell Biopharmaceutical Co., Ltd. Solvate of cyclic peptide compound, preparation method for same, and uses thereof
CN108276478B (zh) * 2014-05-29 2021-09-28 上海天伟生物制药有限公司 环肽类化合物的晶体及其制备方法和用途
CN105693824A (zh) * 2015-08-27 2016-06-22 博瑞生物医药(苏州)股份有限公司 一种降低米卡芬净钠原料药溶剂残留量的方法
KR101880179B1 (ko) * 2016-11-03 2018-07-20 한국생명공학연구원 미카펀진(micafungin) 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 항바이러스용 약학적 조성물
CN108250274A (zh) * 2016-12-28 2018-07-06 浙江华谱新创科技有限公司 米卡芬净高效分离纯化方法
EP3485873A1 (en) * 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN108752430B (zh) * 2018-05-31 2022-02-18 杭州中美华东制药有限公司 米卡芬净钠新晶型及其制备方法
CN111909244A (zh) * 2020-08-14 2020-11-10 卓和药业集团有限公司 一种高纯度米卡芬净前体fr901379的制备方法
CN115785226B (zh) * 2021-09-09 2026-02-24 上海天伟生物制药有限公司 一种棘白菌素药物杂质及其制备、纯化方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901379A (fr) 1943-09-10 1945-07-25 Télégraphie par variations de fréquence
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
IL98506A (en) 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
RU2165423C2 (ru) 1994-10-07 2001-04-20 Фудзисава Фармасьютикал Ко., Лтд. Полипептидное соединение, способ его получения и фармацевтическая композиция
US6227164B1 (en) 1998-04-24 2001-05-08 Cooper Automotive Products, Inc. Insulator shield for spark plug
DK1137663T3 (da) * 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
WO2004014879A1 (en) 2002-08-08 2004-02-19 Fujisawa Pharmaceutical Co., Ltd. New process
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
US9394340B2 (en) * 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
EP2621941A1 (en) * 2010-09-28 2013-08-07 DSM Sinochem Pharmaceuticals Netherlands B.V. Method for isolating a cyclohexapeptide
ES2581562T3 (es) * 2010-09-29 2016-09-06 Shanghai Techwell Biopharmaceutical Co., Ltd Procedimiento para purificar compuestos lipopeptídicos cíclicos o sales de los mismos
WO2012143293A1 (en) * 2011-04-20 2012-10-26 Xellia Pharmaceuticals Aps Method for purification of micafungin

Also Published As

Publication number Publication date
EP2918324A1 (en) 2015-09-16
IL228913A0 (en) 2013-12-31
WO2012143293A1 (en) 2012-10-26
US9132163B2 (en) 2015-09-15
JP2014511886A (ja) 2014-05-19
JP5992507B2 (ja) 2016-09-14
RU2013150600A (ru) 2015-05-27
BR112013026420A2 (pt) 2020-11-03
DK2699327T3 (en) 2015-10-05
IL228913A (en) 2017-03-30
EP2699327A1 (en) 2014-02-26
CA2832145A1 (en) 2012-10-26
KR101944512B1 (ko) 2019-01-31
ES2547827T3 (es) 2015-10-08
EP2699327B1 (en) 2015-07-01
HRP20151033T1 (hr) 2015-11-06
AU2012244435B2 (en) 2017-06-15
CA2832145C (en) 2020-10-20
CN103533995A (zh) 2014-01-22
SI2699327T1 (sl) 2015-11-30
HUE027806T2 (en) 2016-11-28
US20140371423A1 (en) 2014-12-18
RS54240B1 (sr) 2015-12-31
AU2012244435A1 (en) 2013-10-24
KR20140029453A (ko) 2014-03-10
RU2583262C2 (ru) 2016-05-10
CN103533995B (zh) 2016-03-02
PL2699327T3 (pl) 2015-12-31

Similar Documents

Publication Publication Date Title
BR112013008738A2 (pt) processos para purificação de proteínas
ES2547827T8 (es) Procedimiento para la purificación de la micafungina
EP2680775A4 (en) Cryogenic medical system
SMT201600464B (it) Procedimento per la preparazione di esterolo
ES2603028T8 (es) Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos
ZA201305971B (en) Method for the purification of biphephos
BR112013024521A2 (pt) métodos de purificação de proteínas
BR112014008060A2 (pt) sistema de remoção de tecido
DK2679008T3 (da) Multi-metrik filtrering
DK3246416T3 (da) Sikkert sekventeringssystem
EP2742886A4 (en) SURGICAL SYSTEM
BR112014001675A2 (pt) dispositivos de vedação para filtros
BR112014003660A2 (pt) suporte de trocarte
EP2665059A4 (en) Endoscope operation system
EP2696949A4 (en) BINDING
BR112013024413A2 (pt) compostos e métodos para a preparação de diarilpropanos
SG10201606218WA (en) Purified Proteins
HRP20190030T1 (hr) Postupak pročišćavanja protutijela
CO7020857A2 (es) Procedimiento para la preparación de complejos de 68ga
BR112013012094A2 (pt) método para a purifação de misturas
EP2729672A4 (en) NEW CLEANING ARRANGEMENT
BR112013012096A2 (pt) método para a purifação de misturas
BR112013022508A2 (pt) novos compostos de azaespirodecanona
EP2714713A4 (en) PURIFICATION OF ANTIBODIES
EP2714717A4 (en) PHOENIXINPEPTIDE